View in EDS HTML Full Text PDF Full Text

Urolithin A regulates gut: liver axis to ameliorate alcohol-associated liver disease.

Saved in:
Bibliographic Details
Title: Urolithin A regulates gut: liver axis to ameliorate alcohol-associated liver disease.
Authors: Ghosh S; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States., Singh R; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States., Vanwinkle ZM; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States., McClain CJ; Department of Medicine, University of Louisville, Louisville, KY, United States.; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, United States.; Hepatobiology & Toxicology Center, University of Louisville, Louisville, KY, United States.; Alcohol Research Center, University of Louisville, Louisville, KY, United States.; Robley Rex Louisville VAMC, Louisville, KY, United States.; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, KY, United States., Vatsalya V; Department of Medicine, University of Louisville, Louisville, KY, United States.; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, United States.; Alcohol Research Center, University of Louisville, Louisville, KY, United States.; Robley Rex Louisville VAMC, Louisville, KY, United States.; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, KY, United States.; Clinical Laboratory for the Intervention Development of AUD and Organ Severity, University of Louisville, Louisville, KY, United States.; NIAAA, National Institutes of Health, Bethesda, MD, United States., Haribabu B; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States., Vemula PK; Institute for Stem Cell Biology and Regenerative Medicine (inStem), GKVK campus, Bangalore, Karnataka, India., Jala VR; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States.; Alcohol Research Center, University of Louisville, Louisville, KY, United States.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 Jan 19; Vol. 16, pp. 1706111. Date of Electronic Publication: 2026 Jan 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41635923
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Urolithin A regulates gut: liver axis to ameliorate alcohol-associated liver disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ghosh+S%22">Ghosh S</searchLink>; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States.<br /><searchLink fieldCode="AU" term="%22Vanwinkle+ZM%22">Vanwinkle ZM</searchLink>; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States.<br /><searchLink fieldCode="AU" term="%22McClain+CJ%22">McClain CJ</searchLink>; Department of Medicine, University of Louisville, Louisville, KY, United States.; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, United States.; Hepatobiology & Toxicology Center, University of Louisville, Louisville, KY, United States.; Alcohol Research Center, University of Louisville, Louisville, KY, United States.; Robley Rex Louisville VAMC, Louisville, KY, United States.; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, KY, United States.<br /><searchLink fieldCode="AU" term="%22Vatsalya+V%22">Vatsalya V</searchLink>; Department of Medicine, University of Louisville, Louisville, KY, United States.; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY, United States.; Alcohol Research Center, University of Louisville, Louisville, KY, United States.; Robley Rex Louisville VAMC, Louisville, KY, United States.; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, KY, United States.; Clinical Laboratory for the Intervention Development of AUD and Organ Severity, University of Louisville, Louisville, KY, United States.; NIAAA, National Institutes of Health, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Haribabu+B%22">Haribabu B</searchLink>; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States.<br /><searchLink fieldCode="AU" term="%22Vemula+PK%22">Vemula PK</searchLink>; Institute for Stem Cell Biology and Regenerative Medicine (inStem), GKVK campus, Bangalore, Karnataka, India.<br /><searchLink fieldCode="AU" term="%22Jala+VR%22">Jala VR</searchLink>; Department of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, United States.; Alcohol Research Center, University of Louisville, Louisville, KY, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 Jan 19; Vol. 16, pp. 1706111. <i>Date of Electronic Publication: </i>2026 Jan 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41635923
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2025.1706111
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1706111
    Titles:
      – TitleFull: Urolithin A regulates gut: liver axis to ameliorate alcohol-associated liver disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ghosh S
      – PersonEntity:
          Name:
            NameFull: Singh R
      – PersonEntity:
          Name:
            NameFull: Vanwinkle ZM
      – PersonEntity:
          Name:
            NameFull: McClain CJ
      – PersonEntity:
          Name:
            NameFull: Vatsalya V
      – PersonEntity:
          Name:
            NameFull: Haribabu B
      – PersonEntity:
          Name:
            NameFull: Vemula PK
      – PersonEntity:
          Name:
            NameFull: Jala VR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 01
              Text: 2026 Jan 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1